The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...

Researchers have demonstrated that liposomes target tumours more effectively and reduce side effects, while others have observed that these nanomedicines improve the penetration and specificity of ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Chronically high levels of insulin and inflammation are key features of obesity and metabolic syndrome, which mediate cancer ...

A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.

Tariff cuts promise lower import costs, but patient prices may not fall overnight.

A popular over-the-counter supplement that patients with cancer are prescribed or buy on their own to improve hair and nail ...

Ghana has been selected as one of the countries to benefit from a global initiative that offers free quality-assured ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...